Application of Microfluidic Devices for Automated Two‐Step Radiolabeling of Antibodies
Radioimmunoconjugates (RICs) composed of tumor-targeting monoclonal antibodies and radionuclides have been developed for diagnostic and therapeutic application. A new radiolabeling method using microfluidic devices is expected to facilitate simpler and more rapid synthesis of RICs. In the microfluidic method, microfluidic chips can promote the reaction between reactants by mixing them efficiently, and pumping systems enable automated synthesis. In this study, we synthesized RICs by the pre-labeling method, in which the radiometal is coordinated to the chelator and then the radiolabeled chelator is incorporated into the antibodies, using microfluidic devices for the first time. As a result of examining the reaction parameters including the material of mixing units, reaction temperature, and flow rate, RICs with radiochemical purity (RCP) exceeding 90% were obtained. These high-purity RICs were successfully synthesized without any purification simply by pumping three solutions of a chelating agent, radiometal, and antibody into microfluidic devices. Under the same conditions, the RCP of RICs labeled by conventional methods was below 50%. These findings indicate the utility of microfluidic devices for automatic and rapid synthesis of high-quality RICs.
Authors
- Kazuma Nakashima (ORCID: https://orcid.org/0009-0003-3462-7354)
- Masahiro Ono (ORCID: https://orcid.org/0000-0002-2497-039X)
- Hiroyuki Watanabe (ORCID: https://orcid.org/0000-0002-8873-1224)
- Hiroki Jinda
Institutions
- Kyoto University (JP)
Publication Details
- Journal
- Journal of Labelled Compounds and Radiopharmaceuticals
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/jlcr.4119
- Citations
- 1
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Japan Agency for Medical Research and Development